SHARE

November 01, 2021

New York Employers Must Activate Airborne Infectious Disease Exposure Prevention Plans Under NY HERO Act

You've Reached Your
Free Article Limit This Month
Subscribe now to get unlimited access to all Law.com OnPractice content. Your subscription is free.
Subscribe Now

Key Takeaways

  • The exposure plans need not be implemented with respect to work sites over which New York employers do not exercise control, such as personal residences where employees are working from home.
  • Employers that fail to adopt a plan or implement their plans may be subject to civil penalties ranging from $50 to $10,000 for a first offense and may open themselves to lawsuits seeking injunctive relief under the NY HERO Act.
  • The NY HERO Act also contains anti-retaliation provisions which prohibit employers from taking adverse actions against employees for exercising any right or reporting any violation under the NY HERO Act.

On Sept. 6, 2021, New York Gov. Kathy Hochul announced the New York State Department of Health had designated COVID-19 a highly contagious communicable disease that presents a risk of harm to the public under the New York Health and Essential Rights Act (NY HERO Act), which passed May 5, 2021. As a result, NY employers must now activate their disease exposure prevention plans in accordance with the NY HERO Act.

The NY HERO Act mandates that New York employers adopt an "airborne infectious disease exposure prevention plan" within 30 days after the New York Department of Labor publishes model standards of such plans. On July 6, 2021, the DOL published model standards as well as model disease exposure prevention plans for various industries. See GT Alert. Accordingly, New York employers were required

  • by Aug. 5, 2021, to adopt their own disease exposure prevention plan;
  • by Sept. 4, 2021, to distribute the plan to employees; and
  • by Nov. 1, 2021, to allow workers to establish and administer a joint labor-management workplace safety committee (for employers with 10 or more employees only).

Initially as written, the NY HERO Act was not directed to address COVID-19 specifically, and employers were not required to activate or implement their disease exposure prevention plans unless and until the New York State Commissioner of Health designated a disease a "highly contagious communicable disease" that "presents a serious risk of harm to the public health." In light of the governor's Sept. 6, 2021, announcement, employers must now activate their plan by:

  1. Immediately reviewing the worksite's exposure prevention plan and update the plan, if necessary, to ensure it incorporates current information, guidance, and mandatory requirements issued by federal, state, or local governments related to COVID-19;
  2. Finalizing and promptly activating the worksite exposure prevention plan;
  3. Providing a verbal review of the plan to their employees; and
  4. Providing each employee and independent contractor at each work site a copy of the exposure prevention plan in English or in the language identified as the primary language of such employees, if available, and posting the plan at the worksite, such that it is accessible to employees during all work shifts.

Notably, the exposure plans need not be implemented with respect to work sites over which New York employers do not exercise control, such as personal residences where employees are working from home. The NY HERO Act also does not apply to government employers or employers governed by temporary or permanent OSHA standards for COVID-19, such as certain employers in the health care industry.

Employers that fail to adopt a plan or implement their plans may be subject to civil penalties ranging from $50 to $10,000 for a first offense and may open themselves to lawsuits seeking injunctive relief under the NY HERO Act. The NY HERO Act also contains anti-retaliation provisions which prohibit employers from taking adverse actions against employees for exercising any right or reporting any violation under the NY HERO Act.

For more information and updates on the developing situation, visit GT's Health Emergency Preparedness Task Force: Coronavirus Disease 2019 and Business Continuity Amid COVID-19 page.

ALM expressly disclaims any express or implied warranty regarding the OnPractice Content, including any implied warranty that the OnPractice Content is accurate, has been corrected or is otherwise free from errors.

More From Greenberg Traurig

Saddling Up With Dual Agents

By Vanessa Palacio Greenberg Traurig November 02 , 2021

Horse sales can be complex, time consuming, and involve a significant amount of work on the part of a trainer or other knowledgeable individual to facilitate the transaction and help ensure that both buyer and seller adequately understand the transaction and the horse involved.

DOJ Announces Central America Anti-Corruption Tip Line

By Cuneyt A. Akay Greenberg Traurig November 02 , 2021

On Oct. 15, 2021, the Department of Justice (DOJ) announced the creation of a tip line to help assist its Anticorruption Task Force fight corruption in Central America, specifically in the Northern Triangle countries of El Salvador, Guatemala, and Honduras.

Cannabis and the Workplace: New York DOL Clears the Smoke with New Guidance

By Eric B. Sigda Greenberg Traurig November 02 , 2021

With an increasing number of states legalizing the use of recreational marijuana, employment laws are being enacted to address marijuana possession and use.

More From Labor Law

UK: What are the risks of mandatory vaccination policies in the workplace?

By Ben Rouse Littler December 03 , 2021

As workplaces reopen after COVID-19, many employers in the United Kingdom are considering whether to implement policies requiring employees to be fully vaccinated before returning to the workplace.

New York State Department of Health Designates COVID-19 an Airborne Infectious Disease under New York HERO Act

By Marc E Bernstein Paul Hastings LLP November 30 , 2021

On September 6, 2021, Governor Kathy Hochul announced the designation of COVID-19 as a “highly contagious communicable disease that presents a serious risk of harm to the public health” under the NY HERO Act.

Vaccinate or Test (Frequently): President Biden's Mandatory Plan for Large Employers

By Leslie L Abbott Paul Hastings LLP November 30 , 2021

On September 9, 2021, President Biden announced a comprehensive national strategy to combat the ongoing COVID-19 pandemic.

Featured Stories
Publish Your Firm's Content on Law.com OnPractice

Become a publisher and expand your audience reach. More Info

Closeclose
Search
Menu

Working...